{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n None of the provided abstracts explicitly describe or characterize the function of LINC01307 in fibrolamellar carcinoma (FLC). Instead, these studies focus on the unique non‐coding RNA expression profile of FLC—with one study identifying a set of long intergenic non-coding RNAs (lincRNAs), such as LINC00473, that distinguishes FLC from other liver cancers (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Other work emphasizes that the non-coding RNA landscape, including both long non-coding RNAs and microRNAs, is markedly different in FLC compared to normal or other tumor tissues, implicating these molecules in the regulation of oncogenic pathways and signaling cascades such as those mediated by protein kinase A (PKA) resulting from the driver DNAJB1-PRKACA fusion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " A review of the molecular foundations of FLC further reinforces the notion that dysregulation of non-coding RNAs contributes to the disease’s pathogenesis, even though details specific to LINC01307 are not provided."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, although the abstracts collectively underscore the critical role of non-coding RNAs in FLC tumor biology, they do not specifically address the functional role of LINC01307. Additional investigation would be required to determine whether LINC01307 exhibits activities similar to other tumor-associated lincRNAs—such as modulating gene expression or influencing key signaling pathways—or if it plays a distinct role in FLC oncogenesis.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Timothy A Dinh, Eva C M Vitucci, Eliane Wauthier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep44653"}], "href": "https://doi.org/10.1038/srep44653"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28304380"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28304380"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Benjamin A Farber, Gadi Lalazar, Elana P Simon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Non coding RNA analysis in fibrolamellar hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.23325"}], "href": "https://doi.org/10.18632/oncotarget.23325"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29535801"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29535801"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Gadi Lalazar, Sanford M Simon "}, {"type": "b", "children": [{"type": "t", "text": "Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Semin Liver Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1055/s-0037-1621710"}], "href": "https://doi.org/10.1055/s-0037-1621710"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29471565"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29471565"}]}]}]}